Advertisement

Topics

Gottlieb Shifts From Regulatory To Reimbursement Focus In One Of First Post-Commissioner Appearances

18:33 EDT 12 May 2019 | SCRIP

CAR-T reimbursement is concern for former US FDA commissioner Scott Gottlieb in speech at the National Press Club.

      

Related Stories

 

Original Article: Gottlieb Shifts From Regulatory To Reimbursement Focus In One Of First Post-Commissioner Appearances

NEXT ARTICLE

More From BioPortfolio on "Gottlieb Shifts From Regulatory To Reimbursement Focus In One Of First Post-Commissioner Appearances"

Advertisement
Quick Search
Advertisement
Advertisement